Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02734771
Title A Study of Brentuximab Vedotin, Rituximab, and Dose Attenuated CHP in Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL)
Acronym BV mini CHP
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Patrick Reagan
Indications
Therapies
Age Groups: senior
Covered Countries USA

Facility Status City State Zip Country Details
James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester New York 14642 United States Details
University of Virginia Cancer Center Charlottesville Virginia 22908 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field